Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - INTEGRATED BIOPHARMA INC | inbp20180630_10k.htm |
| EX-32.2 - EXHIBIT 32.2 CFO CERTIFICATION - INTEGRATED BIOPHARMA INC | ex_123711.htm |
| EX-32.1 - EXHIBIT 32.1 CEO CERTIFICATION - INTEGRATED BIOPHARMA INC | ex_123710.htm |
| EX-31.2 - EXHIBIT 31.2 CFO CERTIFICATION - INTEGRATED BIOPHARMA INC | ex_123709.htm |
| EX-31.1 - EXHIBIT 31.1 CEO CERTIFICATION - INTEGRATED BIOPHARMA INC | ex_123708.htm |
| EX-21 - EXHIBIT 21 SUBSIDIARIES - INTEGRATED BIOPHARMA INC | ex_123706.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated September 12, 2018, with respect to the consolidated financial statements included in the Annual Report of Integrated Biopharma, Inc. on Form 10-K for the years ended June 30, 2018 and June 30, 2017. We hereby consent to the incorporation by reference of said report in the Registration Statements of Integrated BioPharma, Inc. on Forms S-8 (Nos. 333-37509, 333-87456 and 333-87458) and the Registration Statements on Form S-3 (Nos. 333-144155 and 333-149855).
/s/ Friedman LLP
East Hanover, New Jersey
September 12, 2018